
Chinese medical device companies are accelerating their expansion into Europe as anti-corruption policies at home reduce government-backed hospital purchases of medical devices. Domestic hospital purchases fell by about 12% year-on-year in early 2026, partly due to a new anti-corruption investigation. This decline is negatively impacting the revenue of major Chinese device makers, prompting them to seek growth overseas despite increasing trade protectionism.
No infographic was generated for this story. GreyNews is not leaving this spinning indefinitely.
Analyzed · High confidence (77%)
Same as the summary above — this brief adds the distinct fields below.
Profit squeezing at home
Chinese innovative medical device companies are accelerating their push into the European market.
3 claims still need verification.
No forecast extracted yet.
Chinese innovative medical device companies are accelerating their push into the European market.
South China Morning PostFacing anti-corruption policies and profit pressures at home, Chinese innovative medical device companies are accelerating their push into the European market despite increasing cross-border trade protectionism.
Emotionally neutral rewrite. Same facts, calmer framing.
This angle has contested claims
Chinese innovative medical device companies are accelerating their push into the European market.
South China Morning PostGovernment-backed hospital purchases of medical devices in China fell about 12% year on year in the first five months of 2026.
South China Morning PostThe revenue of major Chinese medical device makers in the first half is being dragged down by these factors.
South China Morning Post